L3VLUP
ProSign in

BVS in the 13F filings

Bioventus Inc · CUSIP 09075A108

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q3 2022Q2 2022Q1 2022Q4 2021Q1 2021
Quarter end
31 Dec 2021
the date the book describes
Filed
10 Feb 2022
up to 45 days after the quarter end
Managers listing it
1
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q3 2021 and Q4 2021; 0 listed it in both
Shares listed
84,300
combined, among listed positions
Reported value
$1.2m
combined, at the quarter end

Managers listing BVS in Q4 2021

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2021, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

1 of 1 holder

ActionFiling
First Eagle Investment Management LLC84,300$1.2munder 0.1%Newnew10 Feb 2022 (the filing on sec.gov)

Largest increases and reductions, by shares

There is no earlier quarter on file to compare with.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
1 in Q4 2021 to 1 in Q2 2026

Tracked managers listing it, at least.

01122Q1 2021Q4 2021Q1 2022Q2 2022Q3 2022Q3 2025Q4 2025Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
BVS by quarter
QuarterHoldersReported valueBuyersSellers
Q1 20212$5.3mn.a.n.a.
Q4 20211$1.2mn.a.n.a.
Q1 20221$2.5mn.a.n.a.
Q2 20221$1.8mn.a.n.a.
Q3 20221$2.5mn.a.n.a.
Q3 20251$369k00
Q4 20251$411k153
Q1 20261$384k812
Q2 20261$398k139

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

BVS and LLY →BVS and JNJ →BVS and VRTX →Choose a stock to compare with BVS →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own BVS, latest filings →Back to the 13F Explorer →